HNRNPA2B1 and cancer: Studies have also provided evidence that hnRNPA2B1 functions as a putative proto-oncogene in some cancers such as glioblastoma, pancreatic cancer, liver cancer, and pancreatic ductal adenocarcinoma (PDAC) (43–46).